Name | PB2 |
---|
Description | PB2 is a tris(2-carboxyethyl)phosphine (TCEP) analogue increasing retinal ganglion (RGCs) cells survival after axotomy in vitro at nanomolar and picomolar concentrations. PB2 is substantially more permeable than TCEP. PB2, as a reducing agent, is highly neuroprotective for RGCs[1]. |
---|---|
Related Catalog | |
In Vitro | PB2 (0.001~100000 nM; 72 hours; RGCs) increases RGC viability[1]. PB2 has modifications that neutralize the polarity of the compounds. The methylesters of PB2 is likely to be cleaved by cytosolic esterases, yielding a polar intracellular intermediate that would be unlikely to cross cell membranes[1]. Cell Viability Assay[1] Cell Line: RGCs Concentration: 0.001~100000 nM Incubation Time: 72 hours Result: Increased RGC viability. |
References |
Molecular Formula | C16H20BO2P |
---|---|
Molecular Weight | 286.11 |